SPOK (NASDAQ: SPOK) revenue
SPOK reported revenue of $139.7m for fiscal 2025, 1.5% more than in fiscal 2024 ($137.7m). Since fiscal 2016 its revenue has fallen by 22.2%, an average decline of 2.7% a year.
SPOK's best year of the last 10 was fiscal 2016. The biggest drop was in fiscal 2020, −7.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $139.7m | +1.5% | $19.7m | 14.1% |
| 2024 | $137.7m | −1.0% | $19.0m | 13.8% |
| 2023 | $139.0m | +3.3% | $21.2m | 15.3% |
| 2022 | $134.5m | −5.4% | $0.2m | 0.2% |
| 2021 | $142.2m | −4.1% | −$27.7m | −19.5% |
| 2020 | $148.2m | −7.6% | −$22.7m | −15.3% |
| 2019 | $160.3m | −5.4% | −$15.8m | −9.9% |
| 2018 | $169.5m | −1.0% | −$3.2m | −1.9% |
| 2017 | $171.2m | −4.7% | $10.7m | 6.3% |
| 2016 | $179.6m | — | $22.2m | 12.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
SPOK revenue compared with its sector
By revenue for its latest fiscal year, SPOK ranks 268th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; SPOK, 1.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 266th | InfuSystem | $143.4m | 6.4% |
| 267th | Beam Therapeutics | $139.7m | 120.0% |
| 268th | SPOK | $139.7m | 1.5% |
| 269th | Quanterix | $138.9m | 1.1% |
| 270th | NRC Health | $137.4m | −4.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of SPOK
- How much revenue did SPOK make in fiscal 2025?
- SPOK reported revenue of $139.7m for fiscal 2025, compared with $137.7m in fiscal 2024.
- How much has the revenue of SPOK fallen?
- Between fiscal 2016 and fiscal 2025 it went from $179.6m to $139.7m: 22.2% less, an average decline of 2.7% a year.
- What was the best year for revenue at SPOK?
- Of its last 10 fiscal years, fiscal 2016, with $179.6m.
- Where does SPOK rank in its sector by revenue?
- It ranks 268th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for SPOK come from?
- From the annual report (Form 10-K) that SPOK files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that SPOK files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on SPOK: the SPOK page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.